![Erik Skullerud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Skullerud
Plus aucun poste en cours
Fortune : 344 $ au 31/05/2024
Historique de carrière de Erik Skullerud
Anciens postes connus de Erik Skullerud
Sociétés | Poste | Début | Fin |
---|---|---|---|
THOR MEDICAL | Directeur Général | 20/09/2021 | 26/08/2022 |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Sales & Marketing | 01/09/2004 | 01/05/2016 |
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 01/01/1997 | 01/05/2000 |
Element Consulting GmbH | Fondateur | 01/01/2017 | - |
Corporate Officer/Principal | 01/01/2017 | - |
Formation de Erik Skullerud
Concordia University | Undergraduate Degree |
Handelshögskolan i Göteborg | Undergraduate Degree |
Statistiques
Internationale
Suède | 3 |
Canada | 2 |
Allemagne | 2 |
Opérationnelle
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Bayer Pharma AG
![]() Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Health Technology |
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Element Consulting GmbH |
- Bourse
- Insiders
- Erik Skullerud
- Expérience